GOMEKLI FDA Approved for Treatment of neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN), Available at Biologics by McKesson
Biologics by McKesson joined a limited distribution network for GOMEKLI, the first FDA-approved treatment for adults and children with NF1-associated plexiform neurofibromas not amenable to complete resection.